circRNA basic information
circBase ID: hsa_circ_0000479
Name: hsa_circ_EPSTI1
Synonym: cyclic RNA EPSTI1
Host Gene: EPSTI1
Genomic location(hg19): chr13:43528083-43544806:-
Genomic location(hg38): chr13:42953947-42970670:-
Subcellular localization: cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0001056
MONDO name: gastric cancer
Disease details: gastric cancer
Disease DO ID:
10534
Disease MeSH ID:
-
Disease NCIt ID:
C9331
Disease ICD11 ID:
1397617262
Disease OMIM ID:
613659
Species: Human
Species details: Homo sapiens
Tissue specimen:

GC tissues; mouse tissues; xenograft tumours

Cell lines:

BGC-823; HGC-27; AGS; MKN-45; MKN-28; GES-1

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: G3BP1, BTRC
Associated microRNA: -
Biological function: Promotes gastric cancer cell proliferation, migration, invasion, EMT, tumorigenesis, tumor growth and metastasis in vitro and in vivo.
Molecular mechanism: hsa_circ_0000479 binds G3BP1 and stabilizes G3BP1 protein by inhibiting BTRC-mediated ubiquitination-mediated degradation through the ubiquitin-proteasome pathway.
Biological pathway or process:

proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); EMT (promotes); ubiquitination (inhibits); other pathway/process (promotes)

Detected method:
Q
M
Validation methods:

RNase R Treatment; Actinomycin D / DRB Stability Assay; RT-qPCR; Microarray; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RIP (RNA Immunoprecipitation); RNA Pull-Down; Co-IP; Transfection; CCK8; EdU Staining; Wound Healing Assay; Transwell Assay; In Vivo Animal Model; H&E Staining; IHC (Immunohistochemistry); Western Blot; Bioinformatics Analysis

Clinical significance:

Upregulated hsa_circ_0000479 expression in GC tissues was associated with poor clinical prognosis and was identified as a potential biomarker and therapeutic target for gastric cancer.

Description:

hsa_circ_0000479/circEPSTI1 is an upregulated cytoplasmic circRNA in gastric cancer that promotes malignant progression, including proliferation, migration, EMT, tumor growth and metastasis. Mechanistically, it interacts with G3BP1 and blocks BTRC-mediated ubiquitination-dependent degradation of G3BP1, supporting the hsa_circ_0000479-G3BP1-BTRC axis as a potential therapeutic target.

Confidence score:

0.8661

Other information
Title:

Hsa_circ_0000479 promotes gastric cancer progression by inhibiting BTRC-mediated ubiquitination of G3BP1.

Journal: Experimental cell research
Published: 2025
PubMed ID: 40320200
Study type:

combined biological and clinical study

Data availability: GSE163416; GSE17423; Data will be made available on request; Supplementary data to this article can be found online at https://doi. org/10.1016/j.yexcr.2025.114585.
Code availability: -